Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy
Authors
Keywords
-
Journal
EMBO Molecular Medicine
Volume 12, Issue 2, Pages -
Publisher
EMBO
Online
2020-01-13
DOI
10.15252/emmm.201810154
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting pericyte–endothelial cell crosstalk by circular RNA-cPWWP2A inhibition aggravates diabetes-induced microvascular dysfunction
- (2019) Chang Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability
- (2018) Xiaoyan Zhou et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Fibroblast Growth Factor 21 Protects Photoreceptor Function in Type 1 Diabetic Mice
- (2018) Zhongjie Fu et al. DIABETES
- MicroRNA-149-5p regulates blood–brain barrier permeability after transient middle cerebral artery occlusion in rats by targeting S1PR2 of pericytes
- (2018) Yan Wan et al. FASEB JOURNAL
- Sema4D/PlexinB1 inhibition ameliorates blood–brain barrier damage and improves outcome after stroke in rats
- (2018) Yi-Fan Zhou et al. FASEB JOURNAL
- FACS isolation of endothelial cells and pericytes from mouse brain microregions
- (2018) Elizabeth E Crouch et al. Nature Protocols
- Semaphorin4D Drives CD8 + T-Cell Lesional Trafficking in Oral Lichen Planus via CXCL9/CXCL10 Upregulations in Oral Keratinocytes
- (2017) Yao Ke et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
- (2017) Sobha Sivaprasad et al. LANCET
- Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy
- (2017) Jiong Hu et al. NATURE
- Predicting outcomes to anti-vascular endothelial growth factor (VEGF) therapy in diabetic macular oedema: a review of the literature
- (2016) Mohammed Ashraf et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Soluble SEMA4D/CD100: A novel immunoregulator in infectious and inflammatory diseases
- (2016) Kimia T. Maleki et al. CLINICAL IMMUNOLOGY
- Truncated netrin-1 contributes to pathological vascular permeability in diabetic retinopathy
- (2016) Khalil Miloudi et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti–Vascular Endothelial Growth Factor Agents in the Treatment of Retinal Disease
- (2016) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Myricetin inhibits advanced glycation end product (AGE)-induced migration of retinal pericytes through phosphorylation of ERK1/2, FAK-1, and paxillin in vitro and in vivo
- (2015) Young Sook Kim et al. BIOCHEMICAL PHARMACOLOGY
- A Human Interactome in Three Quantitative Dimensions Organized by Stoichiometries and Abundances
- (2015) Marco Y. Hein et al. CELL
- Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors
- (2015) A. Patnaik et al. CLINICAL CANCER RESEARCH
- Growth Arrest–Specific 6 Exacerbates Pressure Overload–Induced Cardiac HypertrophyNovelty and Significance
- (2015) Yi-fan Zhao et al. HYPERTENSION
- Generation and preclinical characterization of an antibody specific for SEMA4D
- (2015) Terrence L. Fisher et al. mAbs
- SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease
- (2015) Ernest S. Smith et al. NEUROBIOLOGY OF DISEASE
- Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease
- (2015) Amber L. Southwell et al. NEUROBIOLOGY OF DISEASE
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Integrin β1 controls VE-cadherin localization and blood vessel stability
- (2015) Hiroyuki Yamamoto et al. Nature Communications
- Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins2Akita diabetic mouse
- (2015) Jose R. Hombrebueno et al. Scientific Reports
- Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications
- (2015) Yuji Yoshida et al. Arthritis & Rheumatology
- Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies
- (2015) E. E. Evans et al. Cancer Immunology Research
- Neuronal Cell Death in the Inner Retina and the Influence of Vascular Endothelial Growth Factor Inhibition in a Diabetic Rat Model
- (2014) Hae-Young Lopilly Park et al. AMERICAN JOURNAL OF PATHOLOGY
- Angiopoietin 2 Induces Pericyte Apoptosis via 3 1 Integrin Signaling in Diabetic Retinopathy
- (2014) S. W. Park et al. DIABETES
- Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk
- (2014) Agnieszka Dejda et al. JOURNAL OF CLINICAL INVESTIGATION
- Semaphorins and plexins as therapeutic targets
- (2014) Thomas Worzfeld et al. NATURE REVIEWS DRUG DISCOVERY
- Interruption of Wnt Signaling in Müller Cells Ameliorates Ischemia-Induced Retinal Neovascularization
- (2014) Kelu Kevin Zhou et al. PLoS One
- Neuron-Derived Semaphorin 3A Is an Early Inducer of Vascular Permeability in Diabetic Retinopathy via Neuropilin-1
- (2013) Agustin Cerani et al. Cell Metabolism
- VE-Cadherin and Endothelial Adherens Junctions: Active Guardians of Vascular Integrity
- (2013) Monica Giannotta et al. DEVELOPMENTAL CELL
- Factors affecting visual outcomes in patients with diabetic macular edema treated with ranibizumab
- (2013) R Channa et al. EYE
- Diabetic retinopathy: Neuron protection as a therapeutic target
- (2013) Xinyuan Zhang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Repression of Choroidal Neovascularization Through Actin Cytoskeleton Pathways by MicroRNA-24
- (2013) Qinbo Zhou et al. MOLECULAR THERAPY
- Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation
- (2012) Armelle Le Guelte et al. JOURNAL OF CELL SCIENCE
- Semaphorin 4D/Plexin-B1-Mediated M-Ras GAP Activity Regulates Actin-Based Dendrite Remodeling through Lamellipodin
- (2012) G.-i. Tasaka et al. JOURNAL OF NEUROSCIENCE
- Ranibizumab for Edema of the Macula in Diabetes Study
- (2012) Diana V. Do JAMA Ophthalmology
- Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A
- (2011) J.-S. Joyal et al. BLOOD
- Microvascular Modifications in Diabetic Retinopathy
- (2011) Jennifer T. Durham et al. Current Diabetes Reports
- Endothelial Smad4 Maintains Cerebrovascular Integrity by Activating N-Cadherin through Cooperation with Notch
- (2011) Fangfei Li et al. DEVELOPMENTAL CELL
- Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis
- (2010) Xiaofeng Zhao et al. ADVANCED DRUG DELIVERY REVIEWS
- Diabetic retinopathy
- (2010) Ning Cheung et al. LANCET
- Hypoxia-inducible Factor-1-mediated Regulation of Semaphorin 4D Affects Tumor Growth and Vascularity
- (2009) Qiangming Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of PKC-δ and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy
- (2009) Pedro Geraldes et al. NATURE MEDICINE
- Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis
- (2009) Kip M Connor et al. Nature Protocols
- Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
- (2009) Quan Dong Nguyen et al. OPHTHALMOLOGY
- The many faces of semaphorins: from development to pathology
- (2008) L. Roth et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Angiopoietin-1 Prevents VEGF-Induced Endothelial Permeability by Sequestering Src through mDia
- (2008) Julie Gavard et al. DEVELOPMENTAL CELL
- Pericyte Migration: A Novel Mechanism of Pericyte Loss in Experimental Diabetic Retinopathy
- (2008) F. Pfister et al. DIABETES
- The role of adherens junctions and VE-cadherin in the control of vascular permeability
- (2008) E. Dejana et al. JOURNAL OF CELL SCIENCE
- Retinal ganglion cells in diabetes
- (2008) Timothy S. Kern et al. JOURNAL OF PHYSIOLOGY-LONDON
- Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton
- (2007) Andrea Hartsock et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started